Evidence map›Paper›PMID 27115996›Full record

ArticlePloS one2016

Evidence for a Negative Cooperativity between eIF5A and eEF2 on Binding to the Ribosome.

Danuza Rossi, Natalia M Barbosa, Fabio C Galvão, Paulo E G Boldrin, John W B Hershey, Cleslei F Zanelli, Christopher S Fraser, Sandro R Valentini

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. eIF5A and polyamines restrict mRNA levels in response to ribosome stalls.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Role of eIF5A in Mitochondrial Function.International journal of molecular sciences · 2022
    Review
  7. Article
  8. Frontiers in cellular and infection microbiology · 2020
    Article
  9. Roadblocks and resolutions in eukaryotic translation.Nature reviews. Molecular cell biology · 2018
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Danuza RossiSchool of Pharmaceutical Sciences, UNESP - Univ Estadual Paulista, Department of Biological Sciences, Araraquara, SP, Brazil, 14801.
Natalia M BarbosaSchool of Pharmaceutical Sciences, UNESP - Univ Estadual Paulista, Department of Biological Sciences, Araraquara, SP, Brazil, 14801.
Fabio C GalvãoSchool of Pharmaceutical Sciences, UNESP - Univ Estadual Paulista, Department of Biological Sciences, Araraquara, SP, Brazil, 14801.
Paulo E G BoldrinSchool of Pharmaceutical Sciences, UNESP - Univ Estadual Paulista, Department of Biological Sciences, Araraquara, SP, Brazil, 14801.
John W B HersheyDepartment of Molecular and Cellular Biology, University of California Davis, Davis, CA, United States of America, 95616.
Cleslei F ZanelliSchool of Pharmaceutical Sciences, UNESP - Univ Estadual Paulista, Department of Biological Sciences, Araraquara, SP, Brazil, 14801.
Christopher S FraserDepartment of Molecular and Cellular Biology, University of California Davis, Davis, CA, United States of America, 95616.
Sandro R ValentiniSchool of Pharmaceutical Sciences, UNESP - Univ Estadual Paulista, Department of Biological Sciences, Araraquara, SP, Brazil, 14801.
Universidade Estadual Paulista (Unesp) · BRUniversity of California, Davis · US

Funding

The mechanism of mRNA recruitment to the human ribosome.R01GM092927 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI FRASER, CHRISTOPHER S · 2010 to 2022
$4.1M
NIGMS NIH HHS R01 GM092927
6 · The paper itself

Abstract

eIF5A is the only protein known to contain the essential and unique amino acid residue hypusine. eIF5A functions in both translation initiation due to its stimulation of methionyl-puromycin synthesis and translation elongation, being highly required for peptide-bound formation of specific ribosome stalling sequences such as poly-proline. The functional interaction between eIF5A, tRNA, and eEF2 on the surface of the ribosome is further clarified herein. Fluorescence anisotropy assays were performed to determine the affinity of eIF5A to different ribosomal complexes and reveal its interaction exclusively and directly with the 60S ribosomal subunit in a hypusine-dependent manner (Ki60S-eIF5A-Hyp = 16 nM, Ki60S-eIF5A-Lys = 385 nM). A 3-fold increase in eIF5A affinity to the 80S is observed upon charged-tRNAiMet binding, indicating positive cooperativity between P-site tRNA binding and eIF5A binding to the ribosome. Previously identified conditional mutants of yeast eIF5A, eIF5AQ22H/L93F and eIF5AK56A, display a significant decrease in ribosome binding affinity. Binding affinity between ribosome and eIF5A-wild type or mutants eIF5AK56A, but not eIF5AQ22H/L93F, is impaired in the presence of eEF2 by 4-fold, consistent with negative cooperativity between eEF2 and eIF5A binding to the ribosome. Interestingly, high-copy eEF2 is toxic only to eIF5AQ22H/L93F and causes translation elongation defects in this mutant. These results suggest that binding of eEF2 to the ribosome alters its conformation, resulting in a weakened affinity of eIF5A and impairment of this interplay compromises cell growth due to translation elongation defects.

Indexed as

Cell ProliferationEukaryotic Translation Initiation Factor 5AHeLa CellsHumansLysineMutationPeptide Elongation Factor 2Peptide Initiation FactorsProtein BindingProtein BiosynthesisRibosomesRNA-Binding ProteinsUp-RegulationEukaryotic Translation Initiation Factor 5AhypusineLysinePeptide Elongation Factor 2Peptide Initiation FactorsRNA-Binding Proteins

Identifiers

PMID27115996
PMCPMC4845985
OpenAlexW2342721161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.